Antigen-Specific Therapy for MS Passes Safety Test
Phase 1 study shows hint of immune tolerance to myelin
Phase 1 study shows hint of immune tolerance to myelin
Scientists are reasonably certain that much of the early damage in multiple sclerosis results from...
Laboratory Research, People